Perrigo Co. Plc (New York Stock Exchange:PRGO)

About the company

Perrigo Co. Plc is a healthcare company, which engages in the production of over-the-counter consumer goods and specialty pharmaceutical products. It operates through the following segments: Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals. The Consumer Self-Care Americas segment comprises the U.S., Mexico and Canada consumer healthcare business. The Consumer Self-Care International segment includes branded consumer healthcare business primarily in Europe and consumer focused businesses in the U.K., Australia, and Israel. The Prescription Pharmaceuticals refers to the U.S. prescription pharmaceuticals business. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

11200

CEO

Murray S. Kessler

Exchange

New York Stock Exchange

Website

http://www.perrigo.com

$5B

Total Revenue

11K

Employees

$8B

Market Capitalization

51.65

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$1775M

Operating Margin (in %)

Total operating margin

$416M

Net Margin (in %)

Total net margin

$146M

Dividend Yield (in %)

Dividend per share

$0.82

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 11671.80 1376.00 4.98 18.40 43.06
Catalent, Inc. CTLT 10932.13 2872.00 5.49 104.81 3.63
Perrigo Co. Plc PRGO 7571.99 4837.00 1.30 51.65 3.02
Bausch Health Cos., Inc. BHC 6456.37 8597.00 9.01 -3.41 -21.96
Jazz Pharmaceuticals Plc JAZZ 6247.77 2188.00 2.16 22.84 12.81
United Therapeutics Corp. UTHR 5203.00 1443.00 1.81 10.04 36.59
MyoKardia, Inc. MYOK 4316.64 34.00 12.55 -13.92 -201.73
Axsome Therapeutics, Inc. AXSM 2672.60 None 18.14 -29.71 None
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
Pacira Biosciences, Inc. PCRX 2231.88 435.00 5.98 -5314.00 -0.02
SAGE Therapeutics, Inc. SAGE 2162.16 9.00 2.54 -3.34 -413.06
Corcept Therapeutics, Inc. CORT 2084.98 335.00 4.79 19.64 31.64
Revolution Medicines, Inc. RVMD 1920.45 48.00 4.98 -27.12 -146.29
Prestige Consumer Healthcare, Inc. PBH 1881.39 963.00 1.58 13.27 14.77
Madrigal Pharmaceuticals, Inc. MDGL 1765.35 0.00 4.71 -17.28 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1620.24 440.00 -22.93 19.11 19.14
Innoviva, Inc. INVA 1574.09 285.00 3.72 8.15 66.41
Intercept Pharmaceuticals, Inc. ICPT 1476.16 272.00 -43.93 -4.30 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Zogenix, Inc. ZGNX 1308.15 5.00 3.57 -3.08 -241.62
Supernus Pharmaceuticals, Inc. SUPN 1254.96 402.00 1.99 10.76 28.90
Theravance Biopharma, Inc. TBPH 1196.43 88.00 -8.40 -4.85 -280.80
Revance Therapeutics, Inc. RVNC 1181.11 0.00 4.66 -6.33 41.82
Amphastar Pharmaceuticals, Inc. AMPH 1088.78 327.00 2.72 21.37 15.90
Endo International Plc ENDP 800.28 3014.00 -1.09 -2.85 -9.09
BellRing Brands, Inc. BRBR 764.79 954.00 -0.41 5.80 13.98
Aerie Pharmaceuticals, Inc. AERI 678.96 79.00 5.39 -3.35 -252.92
Assembly Biosciences, Inc. ASMB 676.28 16.00 3.03 -6.80 -601.75
Eagle Pharmaceuticals, Inc. EGRX 671.72 192.00 3.61 266.56 1.29
Collegium Pharmaceutical, Inc. COLL 590.58 299.00 4.23 -45.71 -4.21
Anika Therapeutics, Inc. ANIK 539.98 125.00 1.87 19.48 22.73
Catalyst Pharmaceuticals, Inc. CPRX 487.92 119.00 4.75 11.12 36.09
Intersect ENT, Inc. XENT 411.20 102.00 3.88 -8.24 -48.61
BioDelivery Sciences International, Inc. BDSI 405.26 130.00 5.80 -55.06 -5.01
ANI Pharmaceuticals, Inc. ANIP 391.32 203.00 2.00 -250.85 -0.67
MEI Pharma, Inc. MEIP 356.90 5.00 6.14 -9.15 -539.48
Albireo Pharma, Inc. ALBO 344.37 11.00 3.50 -4.51 -730.55
Mallinckrodt Plc MNK 233.52 3037.00 0.12 -0.19 -39.56
Marinus Pharmaceuticals, Inc. MRNS 168.21 0.00 6.51 -2.50 None
Agile Therapeutics, Inc. AGRX 164.02 None 2.67 -7.94 None
Zynerba Pharmaceuticals, Inc. ZYNE 144.90 0.00 2.38 -4.04 -699.94
Cerecor, Inc. CERC 119.60 7.00 7.65 -5.31 -429.22
Ampio Pharmaceuticals, Inc. AMPE 97.81 1.00 68.40 -5.26 None
AcelRx Pharmaceuticals, Inc. ACRX 94.40 2.00 -1.74 -1.69 -644.25
Evoke Pharma, Inc. EVOK 84.96 None 29.50 -12.64 None
Adamas Pharmaceuticals, Inc. ADMS 70.28 57.00 -4.48 -0.76 -160.44
CTI BioPharma Corp. CTIC 67.85 3.00 3.03 -1.64 -111.83
Aclaris Therapeutics, Inc. ACRS 67.65 4.00 1.19 -0.49 None
Oramed Pharmaceuticals, Inc. ORMP 62.64 3.00 5.04 -4.90 -464.15
Cassava Sciences, Inc. SAVA 56.81 41.00 2.99 -12.46 76.71
Cumberland Pharmaceuticals, Inc. CPIX 49.95 47.00 1.02 -11.10 -9.59
SCYNEXIS, Inc. SCYX 49.93 0.00 10.49 -1.29 -30.84
Natural Alternatives International, Inc. NAII 48.37 114.00 0.66 -12.80 -3.19
Lipocine, Inc. LPCN 37.80 0.00 9.00 -2.52 None
IsoRay, Inc. ISR 37.77 9.00 7.05 -11.27 -36.08
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 34.25 65.00 -2.63 -1.96 -26.74
PLx Pharma, Inc. PLXP 27.99 0.00 -2.68 -2.96 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 19.61 3.00 2.44 -1.66 -264.21
Regulus Therapeutics, Inc. RGLS 14.91 0.00 1.31 -0.70 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.60 8.00 0.67 -0.15 -798.18
Intec Pharma Ltd. NTEC 10.87 None 1.40 -0.25 None
VIVUS, Inc. VVUS 8.91 73.00 -0.20 -0.30 -39.28
Sonoma Pharmaceuticals, Inc. SNOA 7.12 19.00 1.13 -2.28 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
Hepion Pharmaceuticals, Inc. HEPA 5.42 None 1.69 -0.46 None
Tonix Pharmaceuticals Holding Corp. TNXP 4.36 None 1.09 -0.09 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Perrigo Announces The Closing Of A Senior Notes Offering By Its Finance Subsidiary, Perrigo Finance Unlimited Company

12d ago, source: YAHOO!

Perrigo Company plc ("Perrigo" or the "Company") (NYSE; TASE: PRGO) today announced the closing of the previously announced ...

Sol-Gel Technologies Announces Agreements with Perrigo Company for Three New Generic Product Candidates

2d ago, source: YAHOO!

Sol-Gel Technologies, Ltd. (SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin ...

Perrigo To Divest U.K-based Generic Prescription Pharmaceuticals Business - Quick Facts

12d ago, source: Nasdaq

(RTTNews) - Perrigo Co. plc (PRGO) announced Friday that it has reached a definitive agreement to sell its U.K.-based ...

Tower Research Capital LLC TRC Boosts Stake in Perrigo Company PLC (NYSE:PRGO)

4d ago, source: theenterpriseleader.com

Tower Research Capital LLC TRC boosted its stake in Perrigo Company PLC (NYSE:PRGO) by 50.8% during the first quarter, ...

BRIEF-Perrigo Divests Its U.K. Generic Prescription Pharmaceuticals Business For About $195 Mln

12d ago, source: Reuters

PERRIGO FURTHERS ITS CONSUMER-FOCUSED TRANSFORMATION BY DIVESTING ITS U.K. GENERIC PRESCRIPTION PHARMACEUTICALS BUSINESS FOR £156 MILLION OR APPROXIMATELY $195 MILLION * PERRIGO COMPANY - REACHED ...

Federated Hermes Inc. Sells 607 Shares of Perrigo Company PLC (NYSE:PRGO)

8d ago, source: theenterpriseleader.com

Federated Hermes Inc. trimmed its holdings in shares of Perrigo Company PLC (NYSE:PRGO) by 34.5% during the first quarter, ...

Perrigo jettisons UK unit for £156M to PE firm

12d ago, source: Seeking Alpha

NYSE:PRGO) has agreed to sell UK-based unit Rosemont Pharmaceuticals, a maker of generic medicines focused on liquid formulations, to an unnamed private equity shop for £156M (~$1 ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.